Search details
1.
Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancer.
Cancer
; 127(12): 1965-1973, 2021 06 15.
Article
in English
| MEDLINE | ID: mdl-33690902
2.
Accuracy of Information Provided by ChatGPT Regarding Liver Cancer Surveillance and Diagnosis.
AJR Am J Roentgenol
; 221(4): 556-559, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37222278
3.
Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset.
Proc Natl Acad Sci U S A
; 111(17): E1731-9, 2014 Apr 29.
Article
in English
| MEDLINE | ID: mdl-24733940
4.
Physician-reported barriers to referring cancer patients to specialists: prevalence, factors, and association with career satisfaction.
Cancer
; 121(1): 113-22, 2015 Jan 01.
Article
in English
| MEDLINE | ID: mdl-25196776
5.
Intermittent Hormonal Therapy in Biochemical Recurrence of Prostate Cancer Is Worth Considering Because of Mitigation of Cardiovascular Events and Reduction of Other Effects.
Eur Urol Focus
; 9(3): 405-406, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36690547
6.
Implementation of a Telehealth Genetic Testing Station to Deliver Germline Testing for Men With Prostate Cancer.
JCO Oncol Pract
; 19(5): e773-e783, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36649492
7.
Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers.
Urol Oncol
; 41(3): 145.e7-145.e15, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36435709
8.
Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.
medRxiv
; 2023 Mar 10.
Article
in English
| MEDLINE | ID: mdl-37205429
9.
Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study.
Elife
; 122023 10 17.
Article
in English
| MEDLINE | ID: mdl-37846664
10.
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
JAMA Oncol
; 9(10): 1390-1400, 2023 Oct 01.
Article
in English
| MEDLINE | ID: mdl-37589970
11.
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
JAMA Oncol
; 9(1): 128-134, 2023 01 01.
Article
in English
| MEDLINE | ID: mdl-36326731
12.
COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease.
Transl Oncol
; 34: 101709, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37302348
13.
Skeletal-related events after abiraterone or enzalutamide in patients with metastatic castration-resistant prostate cancer: A population-based study using the SEER-Medicare linked dataset.
Urol Oncol
; 40(8): 379.e17-379.e24, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35750560
14.
COVID-19 outcomes in patients with cancer: Findings from the University of California health system database.
Cancer Med
; 11(11): 2204-2215, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35261195
15.
Mobile Audio Recording Technology to Promote Informed Decision Making in Advanced Prostate Cancer.
JCO Oncol Pract
; 18(5): e648-e658, 2022 05.
Article
in English
| MEDLINE | ID: mdl-34932386
16.
The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer.
JNCI Cancer Spectr
; 6(3)2022 05 02.
Article
in English
| MEDLINE | ID: mdl-35657341
17.
Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study.
Cancers (Basel)
; 14(17)2022 Sep 05.
Article
in English
| MEDLINE | ID: mdl-36077869
18.
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19.
Blood Cancer Discov
; 3(3): 181-193, 2022 05 05.
Article
in English
| MEDLINE | ID: mdl-35262738
19.
Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study.
Open Forum Infect Dis
; 9(3): ofac037, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-35198648
20.
Untangling the PROfound Trial for Advanced Prostate Cancer: Is There Really a Role for Olaparib?
Eur Urol
; 79(6): 710-712, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33722420